​

Kronos Bio (KRON) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

KRON Stock Forecast

Kronos Bio (KRON) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $1.00, with a high of $1.00 and a low of $1.00. This represents a 13.64% increase from the last price of $0.88.

High: $1 Avg: $1 Low: $1 Last Closed Price: $0.88

KRON Stock Rating

Kronos Bio stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

KRON Price Target Upside V Benchmarks

TypeNameUpside
StockKronos Bio13.64%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$1.63
Last Closing Price$0.88$0.88$0.88
Upside/Downside--85.23%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 251----1
Mar, 251----1
Feb, 251----1
Jan, 251-1--2
Dec, 24211--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2024Tyler Van BurenPiper Sandler$1.00$0.8813.64%13.64%
May 03, 2024Robert BurnsH.C. Wainwright$2.25$1.03118.45%155.68%
May 23, 2022Piper Sandler$13.00$3.81241.21%1377.27%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 14, 2024Piper SandlerOverweightNeutraldowngrade
Nov 14, 2024Cowen & Co.Holddowngrade
May 03, 2024H.C. WainwrightBuyBuyhold
Dec 19, 2023Raymond JamesBuyBuyhold
May 24, 2022Goldman SachsBuyBuyhold
May 23, 2022Piper SandlerOverweightOverweighthold
Feb 28, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.95$-1.43----
Avg Forecast$-2.04$-1.30$-1.30$-1.35$-1.00$-0.90
High Forecast$-2.00$-1.30$-1.30$-1.35$-1.00$-0.90
Low Forecast$-2.09$-1.30$-1.30$-1.35$-1.00$-0.90
Surprise %-4.41%10.00%----

Revenue Forecast

$0 $9M $18M $27M $36M $45M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.29M$9.85M----
Avg Forecast$5.53M$10.00M$2.17M$6.29M$15.00M$45.00M
High Forecast$6.03M$10.00M$2.17M$6.29M$15.00M$45.00M
Low Forecast$5.02M$10.00M$2.17M$6.29M$15.00M$45.00M
Surprise %13.79%-1.52%----

Net Income Forecast

$-125M $-110M $-95M $-80M $-65M $-50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-112.67M$-86.08M----
Avg Forecast$-118.09M$-75.07M$-75.07M$-77.95M$-57.74M$-51.97M
High Forecast$-115.21M$-75.07M$-75.07M$-77.95M$-57.74M$-51.97M
Low Forecast$-120.97M$-75.07M$-75.07M$-77.95M$-57.74M$-51.97M
Surprise %-4.58%14.67%----

KRON Forecast FAQ

Is Kronos Bio stock a buy?

Kronos Bio stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Kronos Bio is a favorable investment for most analysts.

What is Kronos Bio's price target?

Kronos Bio's price target, set by 5 Wall Street analysts, averages $1 over the next 12 months. The price target range spans from $1 at the low end to $1 at the high end, suggesting a potential 13.64% change from the previous closing price of $0.88.

How does Kronos Bio stock forecast compare to its benchmarks?

Kronos Bio's stock forecast shows a 13.64% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Kronos Bio over the past three months?

  • April 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Kronos Bio’s EPS forecast?

Kronos Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.3, marking a -9.09% decrease from the reported $-1.43 in 2024. Estimates for the following years are $-1.35 in 2026, $-1 in 2027, and $-0.9 in 2028.

What is Kronos Bio’s revenue forecast?

Kronos Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $2.17M, reflecting a -78.00% decrease from the reported $9.85M in 2024. The forecast for 2026 is $6.29M, followed by $15M for 2027, and $45M for 2028.

What is Kronos Bio’s net income forecast?

Kronos Bio's net income forecast for the fiscal year ending in December 2025 stands at $-75.067M, representing a -12.79% decrease from the reported $-86.079M in 2024. Projections indicate $-77.954M in 2026, $-57.744M in 2027, and $-51.97M in 2028.